Table of Content

1 Study Coverage
1.1 Survivin Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Survivin Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Survivin Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Survivin Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global Survivin Antibody Revenue by Region
2.2.1 Global Survivin Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Survivin Antibody Revenue by Region (2018-2024)
2.2.3 Global Survivin Antibody Revenue by Region (2024-2029)
2.2.4 Global Survivin Antibody Revenue Market Share by Region (2018-2029)
2.3 Global Survivin Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global Survivin Antibody Sales by Region
2.4.1 Global Survivin Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Survivin Antibody Sales by Region (2018-2024)
2.4.3 Global Survivin Antibody Sales by Region (2024-2029)
2.4.4 Global Survivin Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Survivin Antibody Sales by Manufacturers
3.1.1 Global Survivin Antibody Sales by Manufacturers (2018-2024)
3.1.2 Global Survivin Antibody Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Survivin Antibody in 2022
3.2 Global Survivin Antibody Revenue by Manufacturers
3.2.1 Global Survivin Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global Survivin Antibody Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Survivin Antibody Revenue in 2022
3.3 Global Key Players of Survivin Antibody, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Survivin Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Survivin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Survivin Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Survivin Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Survivin Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Survivin Antibody Sales by Type
4.1.1 Global Survivin Antibody Historical Sales by Type (2018-2024)
4.1.2 Global Survivin Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global Survivin Antibody Sales Market Share by Type (2018-2029)
4.2 Global Survivin Antibody Revenue by Type
4.2.1 Global Survivin Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global Survivin Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global Survivin Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Survivin Antibody Price by Type
4.3.1 Global Survivin Antibody Price by Type (2018-2024)
4.3.2 Global Survivin Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Survivin Antibody Sales by Application
5.1.1 Global Survivin Antibody Historical Sales by Application (2018-2024)
5.1.2 Global Survivin Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global Survivin Antibody Sales Market Share by Application (2018-2029)
5.2 Global Survivin Antibody Revenue by Application
5.2.1 Global Survivin Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global Survivin Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global Survivin Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Survivin Antibody Price by Application
5.3.1 Global Survivin Antibody Price by Application (2018-2024)
5.3.2 Global Survivin Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Survivin Antibody Market Size by Type
6.1.1 US & Canada Survivin Antibody Sales by Type (2018-2029)
6.1.2 US & Canada Survivin Antibody Revenue by Type (2018-2029)
6.2 US & Canada Survivin Antibody Market Size by Application
6.2.1 US & Canada Survivin Antibody Sales by Application (2018-2029)
6.2.2 US & Canada Survivin Antibody Revenue by Application (2018-2029)
6.3 US & Canada Survivin Antibody Market Size by Country
6.3.1 US & Canada Survivin Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Survivin Antibody Sales by Country (2018-2029)
6.3.3 US & Canada Survivin Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Survivin Antibody Market Size by Type
7.1.1 Europe Survivin Antibody Sales by Type (2018-2029)
7.1.2 Europe Survivin Antibody Revenue by Type (2018-2029)
7.2 Europe Survivin Antibody Market Size by Application
7.2.1 Europe Survivin Antibody Sales by Application (2018-2029)
7.2.2 Europe Survivin Antibody Revenue by Application (2018-2029)
7.3 Europe Survivin Antibody Market Size by Country
7.3.1 Europe Survivin Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Survivin Antibody Sales by Country (2018-2029)
7.3.3 Europe Survivin Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Survivin Antibody Market Size
8.1.1 China Survivin Antibody Sales (2018-2029)
8.1.2 China Survivin Antibody Revenue (2018-2029)
8.2 China Survivin Antibody Market Size by Application
8.2.1 China Survivin Antibody Sales by Application (2018-2029)
8.2.2 China Survivin Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Survivin Antibody Market Size by Type
9.1.1 Asia Survivin Antibody Sales by Type (2018-2029)
9.1.2 Asia Survivin Antibody Revenue by Type (2018-2029)
9.2 Asia Survivin Antibody Market Size by Application
9.2.1 Asia Survivin Antibody Sales by Application (2018-2029)
9.2.2 Asia Survivin Antibody Revenue by Application (2018-2029)
9.3 Asia Survivin Antibody Sales by Region
9.3.1 Asia Survivin Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Survivin Antibody Revenue by Region (2018-2029)
9.3.3 Asia Survivin Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Survivin Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America Survivin Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Survivin Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Survivin Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America Survivin Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Survivin Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Survivin Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America Survivin Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Survivin Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Survivin Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. Overview
11.1.3 Sino Biological, Inc. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sino Biological, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Boster Biological Technology
11.2.1 Boster Biological Technology Company Information
11.2.2 Boster Biological Technology Overview
11.2.3 Boster Biological Technology Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boster Biological Technology Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boster Biological Technology Recent Developments
11.3 Bio-Techne
11.3.1 Bio-Techne Company Information
11.3.2 Bio-Techne Overview
11.3.3 Bio-Techne Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bio-Techne Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bio-Techne Recent Developments
11.4 Thermo Fisher Scientific (China) Co., Ltd.
11.4.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
11.4.2 Thermo Fisher Scientific (China) Co., Ltd. Overview
11.4.3 Thermo Fisher Scientific (China) Co., Ltd. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Thermo Fisher Scientific (China) Co., Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
11.5 CLOUD-CLONE CORP.
11.5.1 CLOUD-CLONE CORP. Company Information
11.5.2 CLOUD-CLONE CORP. Overview
11.5.3 CLOUD-CLONE CORP. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CLOUD-CLONE CORP. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CLOUD-CLONE CORP. Recent Developments
11.6 MyBiosource, Inc.
11.6.1 MyBiosource, Inc. Company Information
11.6.2 MyBiosource, Inc. Overview
11.6.3 MyBiosource, Inc. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 MyBiosource, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MyBiosource, Inc. Recent Developments
11.7 Innovative Research
11.7.1 Innovative Research Company Information
11.7.2 Innovative Research Overview
11.7.3 Innovative Research Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Innovative Research Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Innovative Research Recent Developments
11.8 Wuhan Fine Biotech Co., Ltd.
11.8.1 Wuhan Fine Biotech Co., Ltd. Company Information
11.8.2 Wuhan Fine Biotech Co., Ltd. Overview
11.8.3 Wuhan Fine Biotech Co., Ltd. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Wuhan Fine Biotech Co., Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
11.9 Abbexa
11.9.1 Abbexa Company Information
11.9.2 Abbexa Overview
11.9.3 Abbexa Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Abbexa Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbexa Recent Developments
11.10 ZellBio GmbH
11.10.1 ZellBio GmbH Company Information
11.10.2 ZellBio GmbH Overview
11.10.3 ZellBio GmbH Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 ZellBio GmbH Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ZellBio GmbH Recent Developments
11.11 Biomatik
11.11.1 Biomatik Company Information
11.11.2 Biomatik Overview
11.11.3 Biomatik Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Biomatik Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Biomatik Recent Developments
11.12 Assay Genie
11.12.1 Assay Genie Company Information
11.12.2 Assay Genie Overview
11.12.3 Assay Genie Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Assay Genie Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Assay Genie Recent Developments
11.13 Creative Diagnostics
11.13.1 Creative Diagnostics Company Information
11.13.2 Creative Diagnostics Overview
11.13.3 Creative Diagnostics Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Creative Diagnostics Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Creative Diagnostics Recent Developments
11.14 RayBiotech, Inc.
11.14.1 RayBiotech, Inc. Company Information
11.14.2 RayBiotech, Inc. Overview
11.14.3 RayBiotech, Inc. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 RayBiotech, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 RayBiotech, Inc. Recent Developments
11.15 CUSABIO
11.15.1 CUSABIO Company Information
11.15.2 CUSABIO Overview
11.15.3 CUSABIO Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 CUSABIO Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 CUSABIO Recent Developments
11.16 ZodelBiotec Ltd.
11.16.1 ZodelBiotec Ltd. Company Information
11.16.2 ZodelBiotec Ltd. Overview
11.16.3 ZodelBiotec Ltd. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 ZodelBiotec Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 ZodelBiotec Ltd. Recent Developments
11.17 Geno Technology, Inc.
11.17.1 Geno Technology, Inc. Company Information
11.17.2 Geno Technology, Inc. Overview
11.17.3 Geno Technology, Inc. Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Geno Technology, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Geno Technology, Inc. Recent Developments
11.18 Cepham Life Sciences, Inc
11.18.1 Cepham Life Sciences, Inc Company Information
11.18.2 Cepham Life Sciences, Inc Overview
11.18.3 Cepham Life Sciences, Inc Survivin Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Cepham Life Sciences, Inc Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Cepham Life Sciences, Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Survivin Antibody Industry Chain Analysis
12.2 Survivin Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Survivin Antibody Production Mode & Process
12.4 Survivin Antibody Sales and Marketing
12.4.1 Survivin Antibody Sales Channels
12.4.2 Survivin Antibody Distributors
12.5 Survivin Antibody Customers
13 Market Dynamics
13.1 Survivin Antibody Industry Trends
13.2 Survivin Antibody Market Drivers
13.3 Survivin Antibody Market Challenges
13.4 Survivin Antibody Market Restraints
14 Key Findings in The Global Survivin Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Survivin Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Polyclonal Antibody
Table 4. Global Survivin Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Survivin Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Survivin Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Survivin Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Survivin Antibody Revenue Market Share by Region (2018-2024)
Table 9. Global Survivin Antibody Revenue Market Share by Region (2024-2029)
Table 10. Global Survivin Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Survivin Antibody Sales by Region (2018-2024) & (K Units)
Table 12. Global Survivin Antibody Sales by Region (2024-2029) & (K Units)
Table 13. Global Survivin Antibody Sales Market Share by Region (2018-2024)
Table 14. Global Survivin Antibody Sales Market Share by Region (2024-2029)
Table 15. Global Survivin Antibody Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Survivin Antibody Sales Share by Manufacturers (2018-2024)
Table 17. Global Survivin Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Survivin Antibody Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Survivin Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Survivin Antibody Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Survivin Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Survivin Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Survivin Antibody as of 2022)
Table 23. Global Key Manufacturers of Survivin Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Survivin Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of Survivin Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 28. Global Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 29. Global Survivin Antibody Sales Share by Type (2018-2024)
Table 30. Global Survivin Antibody Sales Share by Type (2024-2029)
Table 31. Global Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Survivin Antibody Revenue Share by Type (2018-2024)
Table 34. Global Survivin Antibody Revenue Share by Type (2024-2029)
Table 35. Survivin Antibody Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Survivin Antibody Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 38. Global Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 39. Global Survivin Antibody Sales Share by Application (2018-2024)
Table 40. Global Survivin Antibody Sales Share by Application (2024-2029)
Table 41. Global Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Survivin Antibody Revenue Share by Application (2018-2024)
Table 44. Global Survivin Antibody Revenue Share by Application (2024-2029)
Table 45. Survivin Antibody Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Survivin Antibody Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Survivin Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Survivin Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Survivin Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Survivin Antibody Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Survivin Antibody Sales by Country (2024-2029) & (K Units)
Table 60. Europe Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 61. Europe Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 62. Europe Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 65. Europe Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 66. Europe Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Survivin Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Survivin Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Survivin Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Survivin Antibody Sales by Country (2018-2024) & (K Units)
Table 72. Europe Survivin Antibody Sales by Country (2024-2029) & (K Units)
Table 73. China Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 74. China Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 75. China Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 78. China Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 79. China Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 82. Asia Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 83. Asia Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 86. Asia Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 87. Asia Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Survivin Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Survivin Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Survivin Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Survivin Antibody Sales by Region (2018-2024) & (K Units)
Table 93. Asia Survivin Antibody Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Survivin Antibody Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Survivin Antibody Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Survivin Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Survivin Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Survivin Antibody Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Survivin Antibody Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Survivin Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Survivin Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Survivin Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Survivin Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Survivin Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Survivin Antibody Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Survivin Antibody Sales by Country (2024-2029) & (K Units)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Description and Major Businesses
Table 109. Sino Biological, Inc. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sino Biological, Inc. Recent Developments
Table 112. Boster Biological Technology Company Information
Table 113. Boster Biological Technology Description and Major Businesses
Table 114. Boster Biological Technology Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Boster Biological Technology Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Boster Biological Technology Recent Developments
Table 117. Bio-Techne Company Information
Table 118. Bio-Techne Description and Major Businesses
Table 119. Bio-Techne Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Bio-Techne Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bio-Techne Recent Developments
Table 122. Thermo Fisher Scientific (China) Co., Ltd. Company Information
Table 123. Thermo Fisher Scientific (China) Co., Ltd. Description and Major Businesses
Table 124. Thermo Fisher Scientific (China) Co., Ltd. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Thermo Fisher Scientific (China) Co., Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
Table 127. CLOUD-CLONE CORP. Company Information
Table 128. CLOUD-CLONE CORP. Description and Major Businesses
Table 129. CLOUD-CLONE CORP. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. CLOUD-CLONE CORP. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. CLOUD-CLONE CORP. Recent Developments
Table 132. MyBiosource, Inc. Company Information
Table 133. MyBiosource, Inc. Description and Major Businesses
Table 134. MyBiosource, Inc. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. MyBiosource, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. MyBiosource, Inc. Recent Developments
Table 137. Innovative Research Company Information
Table 138. Innovative Research Description and Major Businesses
Table 139. Innovative Research Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Innovative Research Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Innovative Research Recent Developments
Table 142. Wuhan Fine Biotech Co., Ltd. Company Information
Table 143. Wuhan Fine Biotech Co., Ltd. Description and Major Businesses
Table 144. Wuhan Fine Biotech Co., Ltd. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Wuhan Fine Biotech Co., Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 147. Abbexa Company Information
Table 148. Abbexa Description and Major Businesses
Table 149. Abbexa Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abbexa Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Abbexa Recent Developments
Table 152. ZellBio GmbH Company Information
Table 153. ZellBio GmbH Description and Major Businesses
Table 154. ZellBio GmbH Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. ZellBio GmbH Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. ZellBio GmbH Recent Developments
Table 157. Biomatik Company Information
Table 158. Biomatik Description and Major Businesses
Table 159. Biomatik Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Biomatik Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Biomatik Recent Developments
Table 162. Assay Genie Company Information
Table 163. Assay Genie Description and Major Businesses
Table 164. Assay Genie Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Assay Genie Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Assay Genie Recent Developments
Table 167. Creative Diagnostics Company Information
Table 168. Creative Diagnostics Description and Major Businesses
Table 169. Creative Diagnostics Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Creative Diagnostics Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Creative Diagnostics Recent Developments
Table 172. RayBiotech, Inc. Company Information
Table 173. RayBiotech, Inc. Description and Major Businesses
Table 174. RayBiotech, Inc. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. RayBiotech, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. RayBiotech, Inc. Recent Developments
Table 177. CUSABIO Company Information
Table 178. CUSABIO Description and Major Businesses
Table 179. CUSABIO Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. CUSABIO Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. CUSABIO Recent Developments
Table 182. ZodelBiotec Ltd. Company Information
Table 183. ZodelBiotec Ltd. Description and Major Businesses
Table 184. ZodelBiotec Ltd. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. ZodelBiotec Ltd. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. ZodelBiotec Ltd. Recent Developments
Table 187. Geno Technology, Inc. Company Information
Table 188. Geno Technology, Inc. Description and Major Businesses
Table 189. Geno Technology, Inc. Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Geno Technology, Inc. Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Geno Technology, Inc. Recent Developments
Table 192. Cepham Life Sciences, Inc Company Information
Table 193. Cepham Life Sciences, Inc Description and Major Businesses
Table 194. Cepham Life Sciences, Inc Survivin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Cepham Life Sciences, Inc Survivin Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Cepham Life Sciences, Inc Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Survivin Antibody Distributors List
Table 200. Survivin Antibody Customers List
Table 201. Survivin Antibody Market Trends
Table 202. Survivin Antibody Market Drivers
Table 203. Survivin Antibody Market Challenges
Table 204. Survivin Antibody Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Survivin Antibody Product Picture
Figure 2. Global Survivin Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Survivin Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global Survivin Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Survivin Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. Survivin Antibody Report Years Considered
Figure 15. Global Survivin Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Survivin Antibody Revenue 2018-2029 (US$ Million)
Figure 17. Global Survivin Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Survivin Antibody Revenue Market Share by Region (2018-2029)
Figure 19. Global Survivin Antibody Sales 2018-2029 ((K Units)
Figure 20. Global Survivin Antibody Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Survivin Antibody Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Survivin Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Survivin Antibody Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Survivin Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Survivin Antibody Sales YoY (2018-2029) & (K Units)
Figure 26. China Survivin Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Survivin Antibody Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Survivin Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Survivin Antibody Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Survivin Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Survivin Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Survivin Antibody in the World: Market Share by Survivin Antibody Revenue in 2022
Figure 33. Global Survivin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 35. Global Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 36. Global Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 37. Global Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Survivin Antibody Revenue Share by Country (2018-2029)
Figure 43. US & Canada Survivin Antibody Sales Share by Country (2018-2029)
Figure 44. U.S. Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 47. Europe Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 48. Europe Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 49. Europe Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 50. Europe Survivin Antibody Revenue Share by Country (2018-2029)
Figure 51. Europe Survivin Antibody Sales Share by Country (2018-2029)
Figure 52. Germany Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 53. France Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 57. China Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 58. China Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 59. China Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 60. China Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 61. Asia Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 62. Asia Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 63. Asia Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 64. Asia Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 65. Asia Survivin Antibody Revenue Share by Region (2018-2029)
Figure 66. Asia Survivin Antibody Sales Share by Region (2018-2029)
Figure 67. Japan Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 71. India Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Survivin Antibody Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Survivin Antibody Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Survivin Antibody Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Survivin Antibody Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Survivin Antibody Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Survivin Antibody Sales Share by Country (2018-2029)
Figure 78. Brazil Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Survivin Antibody Revenue (2018-2029) & (US$ Million)
Figure 83. Survivin Antibody Value Chain
Figure 84. Survivin Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed